Journals / Solunum / 2014 / Cilt: 16 - Sayı: 3

Managing Viral Respiratory Tract Infections in Lung Transplant Recipients

Journal
Solunum
Pages
144–149
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

As preventive measures, we provide vaccination against seasonal influenza for patients and household contacts and recommend specific daily hygiene measures.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Lung transplant recipients require life-long profound immunosuppression, making them prone to respiratory tract infections (RTIs), in particular viral infections, during the winter season.
📊
Key Findings & Data:Since RTIs may have severe consequences, of which acute or chronic allograft dysfunction is feared most, early diagnosis and treatment are recommended.
💡
Conclusion & Impact:As preventive measures, we provide vaccination against seasonal influenza for patients and household contacts and recommend specific daily hygiene measures.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Lung transplant recipients require life-long profound immunosuppression, making them prone to respiratory tract infections (RTIs), in particular viral infections, during the winter season. Since RTIs may have severe consequences, of which acute or chronic allograft dysfunction is feared most, early diagnosis and treatment are recommended. Patients monitor lung function daily at home and are instructed to contact the transplant center in case of signs and symptoms suspicious of RTIs. We then obtain nasopharyngeal swabs for viral and bacteriological examination and initiate pre-emptive treatment with antivirals, broadband antibiotics, and sometimes intravenous immunoglobulins. Treatment duration is guided by virology sampling results. As preventive measures, we provide vaccination against seasonal influenza for patients and household contacts and recommend specific daily hygiene measures.

🔖

Cite This Article

SCHUURMANS, M. M., BENDEN, C., HUBER, L. C. (2014). Managing Viral Respiratory Tract Infections in Lung Transplant Recipients. Solunum, Cilt: 16 - Sayı: 3, 144–149. https://ajindex.com/articles/314501

References (10)

  1. Witt CA, Meyers BF, Hachem RR. Pulmonary infections following lung transplantation. Thorac Surg Clin 2012; 22: p. 403-12.
  2. Renaud C., Campbell AP, Changing epidemiology of respiratory viral infections in hematopoietic cell transplant recipients and solid organ transplant recipients. Curr Opin Infect Dis 2011; 24: 333-43.
  3. Khalifah AP, Hachem RR, Chakinala MM, Schechtman KB, Patterson GA, Schuster DP, et al. Respiratory viral infections are a distinct risk for bron- chiolitis obliterans syndrome and death. Am J Respir Crit Care Med 2004; 170: 181-7.
  4. Chemaly RF, Ghosh S, Bodey GP, Rohatgi N, Safdar A, Keating MJ. Respira- tory viral infections in adults with hematologic malignancies and human stem cell transplantation recipients: a retrospective study at a major can- cer center. Medicine (Baltimore) 2006; 85: 278-87.
  5. Kumar D, Erdman D, Keshavjee S, Peret T, Tellier R, Hadjiliadis D, et al. Clin- ical impact of community-acquired respiratory viruses on bronchiolitis obliterans after lung transplant. Am J Transplant 2005; 5: 2031-6.
  6. Magnusson J, Westin J, Andersson LM, Brittain-Long R, Riise GC.The im- pact of viral respiratory tract infections on long-term morbidity and mor- tality following lung transplantation: a retrospective cohort study using a multiplex PCR panel. Transplantation 2013; 95: 383-8.
  7. Shah PD, JF McDyer. Viral infections in lung transplant recipients. Semin Respir Crit Care Med 2010; 31: 243-54. Speich R, van der Bij W. Epidemiology and management of infections af- ter lung transplantation. Clin Infect Dis 2001; 33 Suppl 1: S58-65. Kumar D, Husain S, Chen MH, Moussa G, Himsworth D, Manuel O. A pro- spective molecular surveillance study evaluating the clinical impact of community-acquired respiratory viruses in lung transplant recipients. Transplantation 2010; 89: 1028-33.
  8. Bridevaux PO, Aubert JD, Soccal PM, Mazza-Stalder J, Berutto C, Rochat T, et al. Incidence and outcomes of respiratory viral infections in lung transplant recipients: a prospective study. Thorax 2014; 69: 32-8. Kumar D1, Michaels MG, Morris MI, Green M, Avery RK, Liu C, et al., Out- comes from pandemic influenza A H1N1 infection in recipients of sol- id-organ transplants: a multicentre cohort study. Lancet Infect Dis 2010; 10: 521-6.
  9. Vu DL, Bridevaux PO, Aubert JD, Soccal PM, Kaiser L. Respiratory viruses in lung transplant recipients: a critical review and pooled analysis of clin- ical studies. Am J Transplant 2011; 11: 1071-8.
  10. Kaiser L., Aubert JD, Pache JD, Deffernez C, Ro